Correlation Between Phio Pharmaceuticals and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Phio Pharmaceuticals and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Conduit Pharmaceuticals.
Diversification Opportunities for Phio Pharmaceuticals and Conduit Pharmaceuticals
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Phio and Conduit is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Phio Pharmaceuticals and Conduit Pharmaceuticals
Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to under-perform the Conduit Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Phio Pharmaceuticals Corp is 5.91 times less risky than Conduit Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Conduit Pharmaceuticals is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 14.00 in Conduit Pharmaceuticals on August 27, 2024 and sell it today you would lose (12.51) from holding Conduit Pharmaceuticals or give up 89.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 36.7% |
| Values | Daily Returns |
Phio Pharmaceuticals Corp vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| Phio Pharmaceuticals Corp |
| Conduit Pharmaceuticals |
Phio Pharmaceuticals and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Phio Pharmaceuticals and Conduit Pharmaceuticals
The main advantage of trading using opposite Phio Pharmaceuticals and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.| Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
| Conduit Pharmaceuticals vs. Entravision Communications | Conduit Pharmaceuticals vs. WiMi Hologram Cloud | Conduit Pharmaceuticals vs. Dolphin Entertainment | Conduit Pharmaceuticals vs. The Coca Cola |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |